Explore an Investigational Vaccine Trial for CMV

‍

Let us be the generation that stands up to cytomegalovirus (CMV), a contagious viral infection that can harm an unborn child. Learn more about a clinical trial for a potential vaccine and how you can join.

CMV is a leading cause of infectious birth defects around the world. CMV is a common viral infection that usually goes unnoticed or only causes mild symptoms in healthy people. But if a woman becomes infected with CMV while she is pregnant, she can pass the infection to her unborn baby. This can cause her child to suffer long-term disability due to birth defects, including hearing loss, or even death in very severe cases. Currently, there is no approved vaccine against CMV. 

‍This link will take you to a website for which the Moderna Privacy Policy does not apply. Moderna does not control or assume responsibility for content on external websites.

Participation in the CMVictory Trial lasts approximately 30 months. You will be compensated for your time. To join this clinical trial, you must be:‍

• A woman between 16-40 years of age

• In good health

• Not pregnant or planning on becoming pregnant within the next 9 months

• In close contact with at least one child 5 years of age or younger for at least 8 hours a week, if age 20 or older

‍